trade leads
Company Logo

COMPANY PROFILE

Shanghai SIPI Pharmaceutical Co., ltd, a state-owned group of companies headquartered in Shanghai, possesses four manufacturing divisions supplying APIs, herbal extract products, bio-chemicals and formulations. Started in the year 1979, SIPI Pharma was set up and invested by Shanghai Institute of Pharmaceutical Industry (SIPI), a most comprehensive and China's supreme pharmaceutical research institute founded in 1957, with 700 strong force of chemical engineers. Initially the company acted as a pilot plant venture of SIPI, offering manufacturing capabilities from gram scale-up to multi-ton lots for compounds under development. Over the nearly 30 years expanding, SIPI Pharma has a formidable presence in pharma field with registered capital over USD10 million, consists of four spacious manufacturing facilities in Shanghai with GMP certified, and more than on thousand employees. The strong R&D strengths of SIPI made her company stand out from all other suppliers: An innovation-based company with disciplined practices of synthesis, providing custom synthesis, contract manufacturing and product sourcing. As a global maker of Azithromycin, Alpha lipoic acid, and many APIs, SIPI Pharma prides itself in exporting since 1996. It's export turnover hit 10 millions USD in 2005. SIPI Pharma is strong&competitive in exporting outsourcing products of chinese origin. Actually the strength comes from SIPI's extensive relationship with large number of chinese pharma manufacturers, who are transferees&beneficiaries of the research findings of SIPI.

Showroom URL

You are visiting: http://www.worldbid.com/sipipharma
Bookmark this page to return at a later time.

Click here to forward this showroom to a friend!
Company Information
Company:   Shanghai SIPI Pharmaceutical Co., Ltd.
Address:   No.858, Yuyuan Road
City:   Shanghai
State/Prov:  
Country:   China
Postal Code:   200050
Phone:   00862152373839
Fax:   +86 21 5237 3100
Contact:   Mr. Bill Zhu
Contact Title:   Marketing
Business:   Manufacturer
Employees:   100 - 1000
Email:   click here
Website:   Click Here
 
Biochemical Pharmaceuticals
Streptokinase (CAS:9002-01-1)
We produce nonrecombinant Streptokinase(SK) in follwoing forms: 1. Crude form (activity 30,000iu/mg) Production capacity:55,000miu/month 2. AP
 
 
APIs
Teniposide, Etoposide
1. Teniposide CAS:29767-20-2 A semi-synthetic podophyllotoxin derivative used in cancer treatment. We produce and offer Teniposide with suprem
 


Worldbid.com Affiliates